{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T12:39:59Z","timestamp":1790167199540,"version":"4.1.0"},"reference-count":125,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T00:00:00Z","timestamp":1581033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["R01AI123359"],"award-info":[{"award-number":["R01AI123359"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"NIAID","doi-asserted-by":"publisher","award":["R01AI127775"],"award-info":[{"award-number":["R01AI127775"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Microbiol."],"DOI":"10.3389\/fmicb.2020.00135","type":"journal-article","created":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T11:32:36Z","timestamp":1581075156000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":49,"title":["Broadly Protective Strategies Against Influenza Viruses: Universal Vaccines and Therapeutics"],"prefix":"10.3389","volume":"11","author":[{"given":"Olivia A.","family":"Vogel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balaji","family":"Manicassamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2020,2,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1962","DOI":"10.4161\/hv.25458","article-title":"Intranasal vaccination with an inactivated whole influenza virus vaccine induces strong antibody responses in serum and nasal mucus of healthy adults","volume":"9","author":"Ainai","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e0204284","DOI":"10.1371\/journal.pone.0210043","article-title":"Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses","volume":"13","author":"Allen","year":"2018","journal-title":"PLoS One"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"pii: 30394","DOI":"10.2807\/1560-7917.ES.2016.21.45.30394","article-title":"Letter to the editor: potential causes of the decreased effectiveness of the influenza A(H1N1)pdm09 strain in live attenuated influenza vaccines","volume":"21","author":"Ambrose","year":"2016","journal-title":"Euro Surveill."},{"key":"ref4","doi-asserted-by":"publisher","first-page":"4368","DOI":"10.1016\/j.vaccine.2015.06.090","article-title":"Strengthening the influenza vaccine virus selection and development process: report of the 3rd WHO informal consultation for improving influenza vaccine virus selection held at WHO headquarters, Geneva, Switzerland, 1-3 April 2014","volume":"33","author":"Ampofo","year":"2015","journal-title":"Vaccine"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"2930","DOI":"10.4049\/jimmunol.168.6.2930","article-title":"Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant-combined vaccines","volume":"168","author":"Asahi","year":"2002","journal-title":"J. Immunol."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s10875-011-9632-5","article-title":"Safety and immunogenicity of multimeric-001--a novel universal influenza vaccine","volume":"32","author":"Atsmon","year":"2012","journal-title":"J. Clin. Immunol."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1128\/AAC.02457-15","article-title":"The Hemagglutinin stem-binding monoclonal antibody VIS410 controls influenza virus-induced acute respiratory distress syndrome","volume":"60","author":"Baranovich","year":"2016","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41541-018-0079-z","article-title":"Cell culture-derived influenza vaccines in the severe 2017\u20132018 epidemic season: a step towards improved influenza vaccine effectiveness","volume":"3","author":"Barr","year":"2018","journal-title":"NPJ Vaccines"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"12388","DOI":"10.1128\/JVI.76.23.12388-12393.2002","article-title":"Compromised influenza virus-specific CD8(+)-T-cell memory in CD4(+)-T-cell-deficient mice","volume":"76","author":"Belz","year":"2002","journal-title":"J. Virol."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1093\/intimm\/11.7.1043","article-title":"Intranasal administration of peptide vaccine protects human\/mouse radiation chimera from influenza infection","volume":"11","author":"Ben-Yedidia","year":"1999","journal-title":"Int. Immunol."},{"key":"ref11","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1016\/S1473-3099(19)30393-7","article-title":"Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial","volume":"20","author":"Bernstein","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"ref12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/cid\/ciq015","article-title":"Potent CD8+ T-cell immunogenicity in humans of a novel heterosubtypic influenza A vaccine, MVA-NP+M1","volume":"52","author":"Berthoud","year":"2011","journal-title":"Clin. Infect. Dis."},{"key":"ref13","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1002\/eji.200636959","article-title":"Efficient induction of mucosal and systemic immune responses by virus-like particles administered intranasally: implications for vaccine design","volume":"38","author":"Bessa","year":"2008","journal-title":"Eur. J. Immunol."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1099\/0022-1317-74-1-143","article-title":"Antibody response to the M2 protein of influenza A virus expressed in insect cells","volume":"74","author":"Black","year":"1993","journal-title":"J. Gen. Virol."},{"key":"ref15","first-page":"1","article-title":"A mosaic hemagglutinin-based influenza virus vaccine candidate protects mice from challenge with divergent H3N2 strains","volume-title":"NPJ Vaccines","author":"Broecker","year":""},{"key":"ref16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/JVI.00840-19","article-title":"Extending the stalk enhances immunogenicity of the influenza virus neuraminidase","volume":"93","author":"Broecker","year":"","journal-title":"J. Virol."},{"key":"ref17","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1038\/371037a0","article-title":"Structure of influenza haemagglutinin at the pH of membrane fusion","volume":"371","author":"Bullough","year":"1994","journal-title":"Nature"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"4720","DOI":"10.1128\/JVI.03152-15","article-title":"Design and characterization of a computationally optimized broadly reactive hemagglutinin vaccine for H1N1 influenza viruses","volume":"90","author":"Carter","year":"2016","journal-title":"J. Virol."},{"key":"ref19","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1128\/JCM.24.1.157-160.1986","article-title":"Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus","volume":"24","author":"Clements","year":"1986","journal-title":"J. Clin. Microbiol."},{"key":"ref20","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1126\/science.1205669","article-title":"A neutralizing antibody selected from plasma cells that binds to group 1 and group 2 influenza A hemagglutinins","volume":"333","author":"Corti","year":"2011","journal-title":"Science"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.biologicals.2009.02.014","article-title":"FluBlok, a next generation influenza vaccine manufactured in insect cells","volume":"37","author":"Cox","year":"2009","journal-title":"Biologicals"},{"key":"ref22","first-page":"21","article-title":"Epidemiologic profile of a new H3N2 variant of influenza A mismatched to vaccine, 2003-2004 influenza season","volume":"31","author":"David","year":"2005","journal-title":"Can. Commun. Dis. Rep."},{"key":"ref23","doi-asserted-by":"publisher","first-page":"3395","DOI":"10.1016\/j.vaccine.2008.04.052","article-title":"Development of a universal influenza A vaccine based on the M2e peptide fused to the papaya mosaic virus (PapMV) vaccine platform","volume":"26","author":"Denis","year":"2008","journal-title":"Vaccine"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nm.3443","article-title":"Broadly neutralizing hemagglutinin stalk-specific antibodies require Fc\u03b3R interactions for protection against influenza virus in vivo","volume":"20","author":"DiLillo","year":"2014","journal-title":"Nat. Med."},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1126\/science.1222908","article-title":"Highly conserved protective epitopes on influenza B viruses","volume":"337","author":"Dreyfus","year":"2012","journal-title":"Science"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.virol.2012.06.003","article-title":"Protection against a lethal H5N1 influenza challenge by intranasal immunization with virus-like particles containing 2009 pandemic H1N1 neuraminidase in mice","volume":"432","author":"Easterbrook","year":"2012","journal-title":"Virology"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"246","DOI":"10.1126\/science.1171491","article-title":"Antibody recognition of a highly conserved influenza virus epitope","volume":"324","author":"Ekiert","year":"2009","journal-title":"Science"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.4049\/jimmunol.0902147","article-title":"Universal vaccine based on ectodomain of matrix protein 2 of influenza A: Fc receptors and alveolar macrophages mediate protection","volume":"186","author":"El Bakkouri","year":"2011","journal-title":"J. Immunol."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1093\/infdis\/jiy103","article-title":"A universal influenza vaccine: the strategic plan for the National Institute of Allergy and Infectious Diseases","volume":"218","author":"Erbelding","year":"2018","journal-title":"J. Infect. Dis."},{"key":"ref30","doi-asserted-by":"publisher","first-page":"I86","DOI":"10.1016\/j.vaccine.2008.11.057","article-title":"Complement and natural antibody are required in the long-term memory response to influenza virus","volume":"26","author":"Fernandez Gonzalez","year":"2008","journal-title":"Vaccine"},{"key":"ref31","volume-title":"Fields virology","author":"Fields","year":"2013"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1016\/S0264-410X(03)00071-9","article-title":"The annual production cycle for influenza vaccine","volume":"21","author":"Gerdil","year":"2003","journal-title":"Vaccine"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1093\/infdis\/jis232","article-title":"A computationally optimized hemagglutinin virus-like particle vaccine elicits broadly reactive antibodies that protect nonhuman primates from H5N1 infection","volume":"205","author":"Giles","year":"2012","journal-title":"J. Infect. Dis."},{"key":"ref34","doi-asserted-by":"publisher","first-page":"3043","DOI":"10.1016\/j.vaccine.2011.01.100","article-title":"A computationally optimized broadly reactive antigen (COBRA) based H5N1 VLP vaccine elicits broadly reactive antibodies in mice and ferrets","volume":"29","author":"Giles","year":"2011","journal-title":"Vaccine"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"12658","DOI":"10.1073\/pnas.0911806107","article-title":"Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses","volume":"107","author":"Grandea","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/0042-6822(83)90465-8","article-title":"Preparation of influenza virus subviral particles lacking the HA1 subunit of hemagglutinin: unmasking of cross-reactive HA2 determinants","volume":"126","author":"Graves","year":"1983","journal-title":"Virology"},{"key":"ref37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6505a1","article-title":"Prevention and control of seasonal influenza with vaccines","volume":"65","author":"Grohskopf","year":"2016","journal-title":"MMWR Recomm. Rep."},{"key":"ref38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15585\/mmwr.rr6602a1","article-title":"Prevention and control of seasonal influenza with vaccines: recommendations of the advisory committee on immunization practices \u2014 United States, 2017\u201318 influenza season","volume":"66","author":"Grohskopf","year":"2017","journal-title":"MMWR Recomm. Rep."},{"key":"ref39","doi-asserted-by":"publisher","first-page":"643","DOI":"10.15585\/mmwr.mm6722a5","article-title":"Update: ACIP recommendations for the use of quadrivalent live attenuated influenza vaccine (LAIV4) - United States, 2018-19 influenza season","volume":"67","author":"Grohskopf","year":"2018","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"ref40","doi-asserted-by":"publisher","first-page":"5774","DOI":"10.1128\/JVI.00137-12","article-title":"Influenza viruses expressing chimeric hemagglutinins: globular head and stalk domains derived from different subtypes","volume":"86","author":"Hai","year":"2012","journal-title":"J. Virol."},{"key":"ref41","doi-asserted-by":"publisher","first-page":"4038","DOI":"10.1016\/j.vaccine.2007.02.060","article-title":"Efficacy of trivalent, cold-adapted, influenza virus vaccine against influenza A (Fujian), a drift variant, during 2003-2004","volume":"25","author":"Halloran","year":"2007","journal-title":"Vaccine"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"296","DOI":"10.4049\/jimmunol.1200571","article-title":"Multiple redundant effector mechanisms of CD8+ T cells protect against influenza infection","volume":"190","author":"Hamada","year":"2013","journal-title":"J. Immunol."},{"key":"ref43","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.4049\/jimmunol.0801814","article-title":"Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge","volume":"182","author":"Hamada","year":"2009","journal-title":"J. Immunol."},{"key":"ref44","doi-asserted-by":"publisher","first-page":"11756","DOI":"10.1128\/JVI.01460-06","article-title":"Cellular immune responses in children and adults receiving inactivated or live attenuated influenza vaccines","volume":"80","author":"He","year":"2006","journal-title":"J. Virol."},{"key":"ref45","doi-asserted-by":"publisher","first-page":"11931","DOI":"10.1073\/pnas.1609316113","article-title":"Epitope specificity plays a critical role in regulating antibody-dependent cell-mediated cytotoxicity against influenza A virus","volume":"113","author":"He","year":"2016","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.it.2017.08.003","article-title":"From original antigenic sin to the universal influenza virus vaccine","volume":"39","author":"Henry","year":"2018","journal-title":"Trends Immunol."},{"key":"ref47","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1093\/infdis\/jir436","article-title":"Live and inactivated influenza vaccines induce similar humoral responses, but only live vaccines induce diverse T-cell responses in young children","volume":"204","author":"Hoft","year":"2011","journal-title":"J. Infect. Dis."},{"key":"ref48","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1126\/science.aac7263","article-title":"A stable trimeric influenza hemagglutinin stem as a broadly protective immunogen","volume":"349","author":"Impagliazzo","year":"2015","journal-title":"Science"},{"key":"ref49","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1002\/jps.20493","article-title":"Pharmaceutical and immunological evaluation of human papillomavirus viruslike particle as an antigen carrier","volume":"95","author":"Ionescu","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"5491","DOI":"10.1128\/JVI.65.10.5491-5498.1991","article-title":"Evolutionary analysis of the influenza A virus M gene with comparison of the M1 and M2 proteins","volume":"65","author":"Ito","year":"1991","journal-title":"J. Virol."},{"key":"ref51","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1038\/nri3665","article-title":"Innate immunity to influenza virus infection","volume":"14","author":"Iwasaki","year":"2014","journal-title":"Nat. Rev. Immunol."},{"key":"ref52","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1038\/s41541-018-0093-1","article-title":"Broadened immunity against influenza by vaccination with computationally designed influenza virus N1 neuraminidase constructs","volume":"3","author":"Job","year":"2018","journal-title":"NPJ Vaccines"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/j.cell.2016.06.043","article-title":"Vaccine-induced antibodies that neutralize group 1 and group 2 influenza A viruses","volume":"166","author":"Joyce","year":"2016","journal-title":"Cell"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.4161\/hv.25181","article-title":"A novel, disruptive vaccination technology: self-adjuvanted RNActive((R)) vaccines","volume":"9","author":"Kallen","year":"2013","journal-title":"Hum. Vaccin. Immunother."},{"key":"ref55","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cell.2016.05.073","article-title":"Structure and function analysis of an antibody recognizing all influenza A subtypes","volume":"166","author":"Kallewaard","year":"2016","journal-title":"Cell"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"S88","DOI":"10.1093\/infdis\/jiy745","article-title":"New vaccine design and delivery technologies","volume":"219","author":"Kanekiyo","year":"2019","journal-title":"J. Infect. Dis."},{"key":"ref57","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1038\/nature12202","article-title":"Self-assembling influenza nanoparticle vaccines elicit broadly neutralizing H1N1 antibodies","volume":"499","author":"Kanekiyo","year":"2013","journal-title":"Nature"},{"key":"ref58","doi-asserted-by":"publisher","first-page":"e0216871","DOI":"10.1371\/journal.pone.0216871","article-title":"Influenza M2 virus-like particle vaccination enhances protection in combination with avian influenza HA VLPs","volume":"14","author":"Kang","year":"2019","journal-title":"PLoS One"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1073\/pnas.87.2.786","article-title":"Independent and disparate evolution in nature of influenza A virus hemagglutinin and neuraminidase glycoproteins","volume":"87","author":"Kilbourne","year":"1990","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/j.virol.2019.07.008","article-title":"Neuraminidase expressing virus-like particle vaccine provides effective cross protection against influenza virus","volume":"535","author":"Kim","year":"2019","journal-title":"Virology"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1038\/mt.2012.246","article-title":"Virus-like particles containing multiple M2 extracellular domains confer improved cross-protection against various subtypes of influenza virus","volume":"21","author":"Kim","year":"2013","journal-title":"Mol. Ther."},{"key":"ref62","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1006\/viro.2002.1625","article-title":"Mechanism of neutralization of influenza virus infectivity by antibodies","volume":"302","author":"Knossow","year":"2002","journal-title":"Virology"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"6542","DOI":"10.1128\/JVI.00641-13","article-title":"Chimeric hemagglutinin influenza virus vaccine constructs elicit broadly protective stalk-specific antibodies","volume":"87","author":"Krammer","year":"2013","journal-title":"J. Virol."},{"key":"ref64","doi-asserted-by":"publisher","first-page":"1337","DOI":"10.1007\/s40265-019-01176-z","article-title":"Cell-based quadrivalent inactivated influenza virus vaccine (flucelvax((R)) tetra\/flucelvax quadrivalent((R))): a review in the prevention of influenza","volume":"79","author":"Lamb","year":"2019","journal-title":"Drugs"},{"key":"ref65","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/0092-8674(85)90211-9","article-title":"Influenza virus M2 protein is an integral membrane protein expressed on the infected-cell surface","volume":"40","author":"Lamb","year":"1985","journal-title":"Cell"},{"key":"ref66","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1016\/S1473-3099(11)70240-7","article-title":"DNA priming and influenza vaccine immunogenicity: two phase 1 open label randomised clinical trials","volume":"11","author":"Ledgerwood","year":"2011","journal-title":"Lancet Infect. Dis."},{"key":"ref67","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.virol.2019.01.017","article-title":"Enhancing the cross protective efficacy of live attenuated influenza virus vaccine by supplemented vaccination with M2 ectodomain virus-like particles","volume":"529","author":"Lee","year":"2019","journal-title":"Virology"},{"key":"ref68","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1093\/cid\/cis327","article-title":"Preliminary assessment of the efficacy of a T-cell-based influenza vaccine, MVA-NP+M1, in humans","volume":"55","author":"Lillie","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref69","doi-asserted-by":"publisher","first-page":"7224","DOI":"10.1128\/JVI.00585-15","article-title":"Cross-reactive neuraminidase-inhibiting antibodies elicited by immunization with recombinant neuraminidase proteins of H5N1 and pandemic H1N1 influenza A viruses","volume":"89","author":"Liu","year":"2015","journal-title":"J. Virol."},{"key":"ref70","doi-asserted-by":"publisher","first-page":"756","DOI":"10.3389\/fimmu.2019.00756","article-title":"Sequential immunization with live-attenuated chimeric Hemagglutinin-based vaccines confers Heterosubtypic immunity against influenza A viruses in a preclinical ferret model","volume":"10","author":"Liu","year":"2019","journal-title":"Front. Immunol."},{"key":"ref71","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1084\/jem.160.3.814","article-title":"In vivo effector function of influenza virus-specific cytotoxic T lymphocyte clones is highly specific","volume":"160","author":"Lukacher","year":"1984","journal-title":"J. Exp. Med."},{"key":"ref72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/cid\/ciz639","article-title":"Pre-existing anti-neuraminidase antibodies are associated with shortened duration of influenza A (H1N1)pdm virus shedding and illness in naturally infected adults","author":"Maier","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"ref73","doi-asserted-by":"publisher","first-page":"10435","DOI":"10.1128\/JVI.01715-13","article-title":"Hemagglutinin stalk-based universal vaccine constructs protect against group 2 influenza A viruses","volume":"87","author":"Margine","year":"2013","journal-title":"J. Virol."},{"key":"ref74","doi-asserted-by":"publisher","first-page":"2847","DOI":"10.1172\/JCI63689","article-title":"Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms","volume":"122","author":"McKinstry","year":"2012","journal-title":"J. Clin. Invest."},{"key":"ref75","doi-asserted-by":"publisher","first-page":"e00417-16","DOI":"10.1128\/mBio.00417-16","article-title":"Evaluation of antihemagglutinin and antineuraminidase antibodies as correlates of protection in an influenza A\/H1N1 virus healthy human challenge model","volume":"7","author":"Memoli","year":"2016","journal-title":"MBio"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"5364","DOI":"10.1038\/s41598-018-23712-9","article-title":"Immunogenicity and protection against influenza H7N3 in mice by modified vaccinia virus ankara vectors expressing influenza virus hemagglutinin or neuraminidase","volume":"8","author":"Meseda","year":"2018","journal-title":"Sci. Rep."},{"key":"ref77","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1093\/infdis\/jiv195","article-title":"Antibody to influenza virus neuraminidase: an independent correlate of protection","volume":"212","author":"Monto","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref78","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1006\/viro.1998.9534","article-title":"Treatment of influenza virus-infected SCID mice with nonneutralizing antibodies specific for the transmembrane proteins matrix 2 and neuraminidase reduces the pulmonary virus titer but fails to clear the infection","volume":"254","author":"Mozdzanowska","year":"1999","journal-title":"Virology"},{"key":"ref79","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1056\/NEJM197206222862502","article-title":"Association of serum anti-neuraminidase antibody with resistance to influenza in man","volume":"286","author":"Murphy","year":"1972","journal-title":"N. Engl. J. Med."},{"key":"ref80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/vaccines6030047","article-title":"A live-attenuated prime, inactivated boost vaccination strategy with chimeric hemagglutinin-based universal influenza virus vaccines provides protection in ferrets: a confirmatory study","volume":"6","author":"Nachbagauer","year":"2018","journal-title":"Vaccines"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1038\/s41541-017-0026-4","article-title":"A universal influenza virus vaccine candidate confers protection against pandemic H1N1 infection in preclinical ferret studies","volume":"2","author":"Nachbagauer","year":"2017","journal-title":"NPJ Vaccines"},{"key":"ref82","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.chom.2013.06.004","article-title":"An in vivo human-plasmablast enrichment technique allows rapid identification of therapeutic influenza A antibodies","volume":"14","author":"Nakamura","year":"2013","journal-title":"Cell Host Microbe"},{"key":"ref83","doi-asserted-by":"publisher","first-page":"1157","DOI":"10.1038\/13484","article-title":"A universal influenza A vaccine based on the extracellular domain of the M2 protein","volume":"5","author":"Neirynck","year":"1999","journal-title":"Nat. Med."},{"key":"ref84","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1128\/JVI.67.5.2552-2558.1993","article-title":"A common neutralizing epitope conserved between the hemagglutinins of influenza A virus H1 and H2 strains","volume":"67","author":"Okuno","year":"1993","journal-title":"J. Virol."},{"key":"ref85","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1038\/nbt.2436","article-title":"Protective efficacy of in vitro synthesized, specific mRNA vaccines against influenza A virus infection","volume":"30","author":"Petsch","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"ref86","doi-asserted-by":"publisher","first-page":"2573","DOI":"10.1073\/pnas.1200039109","article-title":"Hemagglutinin stalk antibodies elicited by the 2009 pandemic influenza virus as a mechanism for the extinction of seasonal H1N1 viruses","volume":"109","author":"Pica","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.4049\/jimmunol.0803467","article-title":"Vaccinia virus-based multivalent H5N1 avian influenza vaccines adjuvanted with IL-15 confer sterile cross-clade protection in mice","volume":"182","author":"Poon","year":"2009","journal-title":"J. Immunol."},{"key":"ref88","doi-asserted-by":"publisher","first-page":"3960","DOI":"10.1016\/j.vaccine.2018.05.057","article-title":"Economic burden of seasonal influenza in the United States","volume":"36","author":"Putri","year":"2018","journal-title":"Vaccine"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1093\/infdis\/jiu539","article-title":"Efficacy and safety of treatment with an anti-m2e monoclonal antibody in experimental human influenza","volume":"211","author":"Ramos","year":"2015","journal-title":"J. Infect. Dis."},{"key":"ref90","doi-asserted-by":"publisher","first-page":"1978","DOI":"10.4049\/jimmunol.173.3.1978","article-title":"Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract","volume":"173","author":"Renegar","year":"2004","journal-title":"J. Immunol."},{"key":"ref91","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1080\/14760584.2016.1254044","article-title":"Fluzone(R) high-dose influenza vaccine","volume":"15","author":"Robertson","year":"2016","journal-title":"Expert Rev. Vaccines"},{"key":"ref92","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/304076a0","article-title":"Single amino acid substitutions in influenza haemagglutinin change receptor binding specificity","volume":"304","author":"Rogers","year":"1983","journal-title":"Nature"},{"key":"ref93","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0042-6822(90)90186-U","article-title":"Cocirculation of two distinct evolutionary lineages of influenza type B virus since 1983","volume":"175","author":"Rota","year":"1990","journal-title":"Virology"},{"key":"ref94","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0166-0934(98)00174-8","article-title":"Influenza virus serology--a comparative study","volume":"78","author":"Rothbarth","year":"1999","journal-title":"J. Virol. Methods"},{"key":"ref95","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1099\/0022-1317-22-1-35","article-title":"The significance of influenza virus neuraminidase in immunity","volume":"22","author":"Rott","year":"1974","journal-title":"J. Gen. Virol."},{"key":"ref96","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1099\/0022-1317-77-7-1483","article-title":"The immunological activity of a deletion mutant of influenza virus haemagglutinin lacking the globular region","volume":"77","author":"Sagawa","year":"1996","journal-title":"J. Gen. Virol."},{"key":"ref97","doi-asserted-by":"publisher","first-page":"e59","DOI":"10.1371\/journal.pmed.0040059","article-title":"Cross-reactive neuraminidase antibodies afford partial protection against H5N1 in mice and are present in unexposed humans","volume":"4","author":"Sandbulte","year":"2007","journal-title":"PLoS Med."},{"key":"ref98","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1073\/pnas.79.4.968","article-title":"Changes in the conformation of influenza virus hemagglutinin at the pH optimum of virus-mediated membrane fusion","volume":"79","author":"Skehel","year":"1982","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref99","doi-asserted-by":"publisher","first-page":"e92153","DOI":"10.1371\/journal.pone.0092153","article-title":"Low 2012-13 influenza vaccine effectiveness associated with mutation in the egg-adapted H3N2 vaccine strain not antigenic drift in circulating viruses","volume":"9","author":"Skowronski","year":"2014","journal-title":"PLoS One"},{"key":"ref100","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1016\/j.vaccine.2006.10.002","article-title":"Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: results from the 2005-2006 season of dual A and B vaccine mismatch in Canada","volume":"25","author":"Skowronski","year":"2007","journal-title":"Vaccine"},{"key":"ref101","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/nm.3350","article-title":"Cellular immune correlates of protection against symptomatic pandemic influenza","volume":"19","author":"Sridhar","year":"2013","journal-title":"Nat. Med."},{"key":"ref102","doi-asserted-by":"publisher","first-page":"373","DOI":"10.3390\/vaccines3020373","article-title":"Influenza vaccination strategies: comparing inactivated and live attenuated influenza vaccines","volume":"3","author":"Sridhar","year":"2015","journal-title":"Vaccines"},{"key":"ref103","doi-asserted-by":"publisher","first-page":"515","DOI":"10.18388\/abp.2014_1873","article-title":"DNA vaccines against influenza","volume":"61","author":"Stachyra","year":"2014","journal-title":"Acta Biochim. Pol."},{"key":"ref104","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/mBio.00018-10","article-title":"Influenza virus vaccine based on the conserved hemagglutinin stalk domain","volume":"1","author":"Steel","year":"2010","journal-title":"MBio"},{"key":"ref105","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.1002\/eji.200737254","article-title":"Synthetic multi-epitope peptides identified in silico induce protective immunity against multiple influenza serotypes","volume":"37","author":"Stoloff","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"ref106","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nsmb.1566","article-title":"Structural and functional bases for broad-spectrum neutralization of avian and human influenza A viruses","volume":"16","author":"Sui","year":"2009","journal-title":"Nat. Struct. Mol. Biol."},{"key":"ref107","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/JVI.00333-19","article-title":"Development of influenza B universal vaccine candidates using the \u201cmosaic\u201d Hemagglutinin approach","volume":"93","author":"Sun","year":"2019","journal-title":"J. Virol."},{"key":"ref108","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1016\/0264-410X(90)90250-P","article-title":"Functional role of respiratory tract haemagglutinin-specific IgA antibodies in protection against influenza","volume":"8","author":"Tamura","year":"1990","journal-title":"Vaccine"},{"key":"ref109","doi-asserted-by":"publisher","first-page":"10890","DOI":"10.1073\/pnas.1502374112","article-title":"A broadly neutralizing human monoclonal antibody is effective against H7N9","volume":"112","author":"Tharakaraman","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref110","doi-asserted-by":"publisher","first-page":"e3942","DOI":"10.1371\/journal.pone.0003942","article-title":"Heterosubtypic neutralizing monoclonal antibodies cross-protective against H5N1 and H1N1 recovered from human IgM+ memory B cells","volume":"3","author":"Throsby","year":"2008","journal-title":"PLoS One"},{"key":"ref111","doi-asserted-by":"publisher","first-page":"E28","DOI":"10.15167\/2421-4248\/jpmh2016.57.1.600","article-title":"Quadrivalent influenza vaccine: a new opportunity to reduce the influenza burden","volume":"57","author":"Tisa","year":"2016","journal-title":"J. Prev. Med. Hyg."},{"key":"ref112","doi-asserted-by":"publisher","first-page":"4198","DOI":"10.1016\/j.vaccine.2018.06.007","article-title":"Protection by universal influenza vaccine is mediated by memory CD4 T cells","volume":"36","author":"Valkenburg","year":"2018","journal-title":"Vaccine"},{"key":"ref113","doi-asserted-by":"publisher","first-page":"5676","DOI":"10.1073\/pnas.1403684111","article-title":"IL-15 adjuvanted multivalent vaccinia-based universal influenza vaccine requires CD4+ T cells for heterosubtypic protection","volume":"111","author":"Valkenburg","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref114","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/BF01318995","article-title":"Monoclonal antibodies demonstrate accessible HA2 epitopes in minor subpopulation of native influenza virus haemagglutinin molecules","volume":"130","author":"Vareckova","year":"1993","journal-title":"Arch. Virol."},{"key":"ref115","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/0042-6822(88)90640-X","article-title":"Protection against lethal influenza with neuraminidase","volume":"164","author":"Webster","year":"1988","journal-title":"Virology"},{"key":"ref116","doi-asserted-by":"publisher","first-page":"S25","DOI":"10.1164\/ajrccm\/152.4_Pt_2.S25","article-title":"Interspecies transmission of influenza viruses","volume":"152","author":"Webster","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref117","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/289366a0","article-title":"Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution","volume":"289","author":"Wilson","year":"1981","journal-title":"Nature"},{"key":"ref118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/JVI.01581-17","article-title":"Computationally optimized broadly reactive hemagglutinin elicits hemagglutination inhibition antibodies against a panel of H3N2 influenza virus cocirculating variants","volume":"91","author":"Wong","year":"2017","journal-title":"J. Virol."},{"key":"ref119","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1016\/j.chom.2019.04.013","article-title":"Preventing an antigenically disruptive mutation in egg-based H3N2 seasonal influenza vaccines by mutational incompatibility","volume":"25","author":"Wu","year":"2019","journal-title":"Cell Host Microbe"},{"key":"ref120","doi-asserted-by":"publisher","first-page":"e1006682","DOI":"10.1371\/journal.ppat.1006682","article-title":"A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine","volume":"13","author":"Wu","year":"2017","journal-title":"PLoS Pathog."},{"key":"ref121","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1038\/273238a0","article-title":"Transfer of specific cytotoxic T lymphocytes protects mice inoculated with influenza virus","volume":"273","author":"Yap","year":"1978","journal-title":"Nature"},{"key":"ref122","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1038\/nm.3927","article-title":"Hemagglutinin-stem nanoparticles generate heterosubtypic influenza protection","volume":"21","author":"Yassine","year":"2015","journal-title":"Nat. Med."},{"key":"ref123","doi-asserted-by":"publisher","first-page":"2762","DOI":"10.1128\/JVI.62.8.2762-2772.1988","article-title":"Influenza A virus M2 protein: monoclonal antibody restriction of virus growth and detection of M2 in virions","volume":"62","author":"Zebedee","year":"1988","journal-title":"J. Virol."},{"key":"ref124","doi-asserted-by":"publisher","first-page":"6644","DOI":"10.1128\/JVI.79.11.6644-6654.2005","article-title":"Influenza type A virus escape mutants emerge in vivo in the presence of antibodies to the ectodomain of matrix protein 2","volume":"79","author":"Zharikova","year":"2005","journal-title":"J. Virol."},{"key":"ref125","doi-asserted-by":"publisher","first-page":"12578","DOI":"10.1073\/pnas.1712377114","article-title":"Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains","volume":"114","author":"Zost","year":"2017","journal-title":"Proc. Natl. Acad. Sci. USA"}],"container-title":["Frontiers in Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.00135\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T11:32:39Z","timestamp":1581075159000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/article\/10.3389\/fmicb.2020.00135\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,7]]},"references-count":125,"alternative-id":["10.3389\/fmicb.2020.00135"],"URL":"https:\/\/doi.org\/10.3389\/fmicb.2020.00135","relation":{},"ISSN":["1664-302X"],"issn-type":[{"value":"1664-302X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,7]]},"article-number":"135"}}